Cognition Therapeutics finishes enrolment in dementia drug trial
The study is evaluating the safety of CT1812, a new treatment for adults with mild-to-moderate dementia with Lewy bodies.
The study is evaluating the safety of CT1812, a new treatment for adults with mild-to-moderate dementia with Lewy bodies.
The observational study will assess the clinical and workflow benefits of using Hyperfine’s Swoop system in detecting amyloid abnormalities in Alzheimer’s patients.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
Cleerly touts new data for AI cardiovascular software
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints
Gedeon Richter adopts TransPerfect’s trial management solutions